229 related articles for article (PubMed ID: 7930545)
21. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review.
van Rijen MM; Bonten M; Wenzel RP; Kluytmans JA
J Antimicrob Chemother; 2008 Feb; 61(2):254-61. PubMed ID: 18174201
[TBL] [Abstract][Full Text] [Related]
22. The preventive effects of mupirocin against nasotracheal intubation-related bacterial carriage.
Takahashi S; Minami K; Ogawa M; Miyamoto H; Ikemura K; Shigematsu A; Taniguchi H
Anesth Analg; 2003 Jul; 97(1):222-5, table of contents. PubMed ID: 12818970
[TBL] [Abstract][Full Text] [Related]
23. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
[TBL] [Abstract][Full Text] [Related]
24. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.
Hurdle JG; O'Neill AJ; Mody L; Chopra I; Bradley SF
J Antimicrob Chemother; 2005 Dec; 56(6):1166-8. PubMed ID: 16275681
[TBL] [Abstract][Full Text] [Related]
25. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus.
Bertino JS
Am J Health Syst Pharm; 1997 Oct; 54(19):2185-91. PubMed ID: 9331438
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
27. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.
Doebbeling BN; Breneman DL; Neu HC; Aly R; Yangco BG; Holley HP; Marsh RJ; Pfaller MA; McGowan JE; Scully BE
Clin Infect Dis; 1993 Sep; 17(3):466-74. PubMed ID: 8218691
[TBL] [Abstract][Full Text] [Related]
28. Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: proceeding with caution.
Boyce JM
Infect Control Hosp Epidemiol; 1996 Dec; 17(12):775-9. PubMed ID: 8985762
[No Abstract] [Full Text] [Related]
29. New strategies for the use of mupirocin for the prevention of serious infection.
Mehtar S
J Hosp Infect; 1998 Sep; 40 Suppl B():S39-44. PubMed ID: 9777532
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of nasal carriage of Staphylococcus aureus and susceptibility of isolates to methicillin and mupirocin among healthcare workers in an Iranian Hospital.
Rahbar M; Yaghoobi M; Kia-Darbandsari B
Infect Control Hosp Epidemiol; 2006 Mar; 27(3):323-5. PubMed ID: 16532427
[No Abstract] [Full Text] [Related]
31. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride.
Rohr U; Mueller C; Wilhelm M; Muhr G; Gatermann S
J Hosp Infect; 2003 Aug; 54(4):305-9. PubMed ID: 12919762
[TBL] [Abstract][Full Text] [Related]
32. Elimination of Staphylococcus aureus nasal carriage in intensive care patients lowers infection rates.
Akhtar Danesh L; Saiedi Nejad Z; Sarmadian H; Fooladvand S; van Belkum A; Ghaznavi-Rad E
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):333-338. PubMed ID: 31720943
[TBL] [Abstract][Full Text] [Related]
33. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness.
Boelaert JR; De Baere YA; Geernaert MA; Godard CA; Van Landuyt HW
J Hosp Infect; 1991 Sep; 19 Suppl B():41-6. PubMed ID: 1684192
[TBL] [Abstract][Full Text] [Related]
34. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.
Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA
Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients.
Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L
Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563
[TBL] [Abstract][Full Text] [Related]
36. Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin.
Boelaert JR; Van Landuyt HW; Gordts BZ; De Baere YA; Messer SA; Herwaldt LA
Infect Control Hosp Epidemiol; 1996 Dec; 17(12):809-11. PubMed ID: 8985768
[TBL] [Abstract][Full Text] [Related]
37. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.
Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923
[TBL] [Abstract][Full Text] [Related]
39. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections.
Wilcox MH; Hall J; Pike H; Templeton PA; Fawley WN; Parnell P; Verity P
J Hosp Infect; 2003 Jul; 54(3):196-201. PubMed ID: 12855234
[TBL] [Abstract][Full Text] [Related]
40. Nasal mupirocin treatment of pharynx-colonized methicillin resistant Staphylococcus aureus: preliminary study with 10 carrier infants.
Hayakawa T; Hayashidera T; Katsura S; Yoneda K; Kusunoki T
Pediatr Int; 2000 Feb; 42(1):67-70. PubMed ID: 10703239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
